SENS Stock Analysis: Buy, Sell, or Hold?
SENS - Senseonics Holdings, Inc.
$5.77
-0.05 (-0.86%)
▼
5d:
+14.71%
30d:
-14.77%
90d:
-23.17%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Smart Money Accumulation
SENS is down 18.9% this week, but smart money is accumulating calls. Top strike: $7.5 2026-07-17 with 1,882 OI. Call ratio: 82% View Scanner →
Strength: 10.0/10
Get Alerted When SENS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called SENS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SENS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SENS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: SENS is currently trading at $5.77, which is considered slightly low relative to its 30-day fair value range of $5.68 to $7.13.
Technical Outlook: Technically, SENS is in a downtrend. The price is approaching resistance at $5.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.42 (+201.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SENS is in a downtrend. The price is approaching resistance at $5.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.42 (+201.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$5.68 -
$7.13
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 201.8% below Wall St target ($17.42)
Trading Range Analysis
30-Day Trading Range
$5.68 -
$7.13
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.79
Resistance Level
$5.94
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.54
Wall Street Target
$17.42
(+201.8%)
Revenue Growth (YoY)
87.2%
Profit Margin
-214.2%
Share & Embed Analysis
Last updated: May 18, 2026 5:04 AM ET
Data refreshes hourly during market hours. Next update: 6:04 AM
Data refreshes hourly during market hours. Next update: 6:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SENS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Douglas A Roeder
BUY
17500 shares
2026-03-13
Timothy T Goodnow
BUY
17225 shares
2026-03-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
